Format

Send to

Choose Destination
Antiviral Res. 2015 May;117:110-4. doi: 10.1016/j.antiviral.2015.02.013. Epub 2015 Mar 6.

Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.

Author information

1
Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
2
Department of Medical Microbiology, Academic Medical Center, Amsterdam, The Netherlands.
3
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, USA.
4
Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
5
Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. Electronic address: F.J.M.vanKuppeveld@uu.nl.

Abstract

Enteroviruses, e.g., polio-, coxsackie- and rhinoviruses, constitute a large genus within the Picornaviridae family of positive-strand RNA viruses and include many important pathogens linked to a variety of acute and chronic diseases. Despite their huge medical and economic impact, no approved antiviral therapy is yet available. Recently, the oxysterol-binding protein (OSBP) was implicated as a host factor for enterovirus replication. Here, we investigated the antiviral activity of the natural compound OSW-1, a ligand of OSBP that is under investigation as an anti-cancer drug. OSW-1 potently inhibited the replication of all enteroviruses tested, with IC50 values in the low nanomolar range, acted at the genome replication stage and was effective in all tested cell types of three different species. Importantly, OSBP overexpression rescued viral replication, demonstrating that the antiviral effect of OSW-1 is due to targeting OSBP. Together, we here report the anti-enterovirus activity of the natural anti-cancer compound OSW-1.

KEYWORDS:

Antiviral; Coxsackievirus; Enterovirus; Oxysterol-binding protein; Replication

PMID:
25752737
DOI:
10.1016/j.antiviral.2015.02.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center